Short communicationHeparin inhibits dengue-2 virus infection of five human liver cell lines
Section snippets
Acknowledgements
We thank Dr. Jyh-Hsiung Huang, who is from CDC of Taiwan, for providing dengue-1, -2, -3 and -4 viruses and JEV.
References (19)
- et al.
Development of a novel mouse model for dengue virus infection
Virology
(1999) - et al.
Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis
Hum. Pathol.
(1999) - et al.
Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes
Hepatology
(2000) - et al.
Light-independent inactivation of Dengue-2 virus by carboxyfullerene C3 isomer
Virology
(2000) - et al.
Involvement of oxidative stress, NF-IL-6 and RANTES expression in dengue-2 virus infected human liver cells
Virology
(2000) - et al.
Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection
Virology
(2001) - et al.
Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains
Virus Res.
(2001) - et al.
Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation
J. Virol.
(2000) - et al.
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Nat. Med.
(1997)
There are more references available in the full text version of this article.
Cited by (119)
Expanding the synthesis of a library of potent glucuronic acid glycodendrons for Dengue virus inhibition
2023, Bioorganic ChemistryHeparin: An old drug for new clinical applications
2022, Carbohydrate PolymersDengue structural proteins as antiviral drug targets: Current status in the drug discovery & development
2021, European Journal of Medicinal ChemistryCitation Excerpt :They observed that in the plaque formation assay, the IC50 in PL0146 strain of DENV 2 reduced the viral titer by 0.3 μg/mL and in New Guinea C strain was about 3 μg/mL. On average, the IC50 observed was 1.5 μg/mL [68]. Therefore they successfully reported that HS mimetics could be an attractive choice for designing new small molecules.
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
2021, International Journal of Biological Macromolecules
Copyright © 2002 Elsevier Science B.V. All rights reserved.